首页> 外文期刊>Bulletin of Faculty of Pharmacy, Cairo University >Enhanced dissolution of meloxicam from orodispersible tablets prepared by different methods
【24h】

Enhanced dissolution of meloxicam from orodispersible tablets prepared by different methods

机译:美洛昔康从不同方法制备的口腔分散片中的溶出度提高

获取原文
获取外文期刊封面目录资料

摘要

The objective of this study was formulation, development and evaluation of meloxicam orodispersible tablets. ODTs were prepared by two methods including sublimation technique where different subliming agents like camphor, menthol and thymol were used with Ac-Di-Sol as a superdisintegrant. Each subliming agent was used in three different concentrations (5, 10 and 15% w/w). Tablets were first prepared and later exposed to vacuum. Meloxicam ODTs were also prepared by freeze-drying an aqueous dispersion of meloxicam containing a matrix former, a sugar alcohol, and a collapse protectant. In addition, different disintegration accelerators were tested (each in 1% w/v) including PVP K25, PVP K90, PEG 6000, PEG 4000, PEG 400, tween 80 and tween 20. The prepared ODTs from two methods were evaluated for weight variation, thickness, drug content, friability, hardness, wetting time, in vitro disintegration time and in vitro dissolution study. The best formulation was subjected to stability testing for 3months at temperatures 40°C and 75% relative humidity and at 60°C. All formulations showed disintegration time ranging from 1 to 46s. All the prepared formulae complied with the pharmacopoeial requirements of the drug contents. T17 gave the best in vitro disintegration and dissolution results. ODT formula T17 has shown no appreciable changes with respect to physical characters, meloxicam content and dissolution profiles when stored at elevated temperatures. In conclusion the results of this work suggest that orodispersible tablets of meloxicam with rapid disintegration time, fast drug release and good hardness can be efficiently and successfully formulated by employing freeze drying and sublimation methods.
机译:这项研究的目的是美洛昔康口腔分散片的配制,开发和评估。 ODT是通过两种方法制备的,包括升华技术,其中将不同的升华剂(如樟脑,薄荷醇和百里酚)与Ac-Di-Sol一起用作超级崩解剂。每种升华剂均以三种不同浓度(5%,10%和15%w / w)使用。首先制备片剂,然后将其暴露于真空中。美洛昔康ODTs也可以通过将含有基质形成剂,糖醇和崩解保护剂的美洛昔康的水性分散液冷冻干燥而制得。另外,测试了不同的崩解促进剂(每种以1%w / v计),包括PVP K25,PVP K90,PEG 6000,PEG 4000,PEG 400,吐温80和吐温20。评估了两种方法制备的ODT的重量变化。 ,厚度,药物含量,脆性,硬度,润湿时间,体外崩解时间和体外溶出度研究。最佳配方在40°C,75%相对湿度和60°C的温度下进行了3个月的稳定性测试。所有配方均显示崩解时间为1至46s。所有制备的配方均符合药物含量的药典要求。 T17具有最佳的体外崩解和溶解效果。当在高温下储存时,ODT公式T17在物理特性,美洛昔康含量和溶出度方面未显示任何明显变化。总之,这项工作的结果表明,采用冷冻干燥和升华方法可以有效地成功配制美洛昔康的口腔分散片,崩解时间短,药物释放快,硬度高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号